ELEDON PHARMACEUTICALS INC. - COMMON STOCK

Eledon Pharmaceuticals Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Pancreatic Islet Cell Transplantation

09 6 2022 08:00:01 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Present at the Jefferies Healthcare Conference

02 6 2022 16:05:00 提供 Nasdaq GlobeNewswire

Eledon Announces Positive Topline Results from Phase 2a Trial of Tegoprubart Demonstrating Safety, Target Engagement, and Biomarker Response in Patients Living with Amyotrophic Lateral Sclerosis

31 5 2022 06:00:00 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals Reports First Quarter 2022 Operating and Financial Results

12 5 2022 16:01:00 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals Announces First Patient Dosed in Phase 2a Trial Evaluating Tegoprubart in IgA Nephropathy

09 5 2022 08:00:02 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022

05 5 2022 16:05:00 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Participate in LifeSci Partners Immunology & Inflammation Symposium

03 5 2022 16:05:00 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Participate in 18th Annual Noble Capital Markets Investor Conference

18 4 2022 16:05:00 提供 Nasdaq GlobeNewswire

Eledon to Host Virtual R&D Day on Thursday, April 28, 2022

14 4 2022 16:05:00 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Operating and Financial Results

24 3 2022 16:01:00 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 24, 2022

17 3 2022 08:00:02 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals Provides Corporate Update and 2022 Outlook

14 2 2022 08:00:01 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Participate in 11th Annual SVB Leerink Global Healthcare Conference

08 2 2022 16:05:00 提供 Nasdaq GlobeNewswire